These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1721766)

  • 1. [Activated monocytes involved in allograft rejection of rats: spontaneous plaque-forming cell as a new monocyte effector].
    Ishibashi M; Moutabarrik A; Kameoka H; Kokado Y; Takahara S; Jiang HS; Takano Y; Sonoda T
    Hinyokika Kiyo; 1991 Oct; 37(10):1135-40. PubMed ID: 1721766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific hemolytic effector of activated macrophages as activation marker of allograft rejection.
    Ishibashi M; Moutabarrik A; Kameoka H; Takano Y; Jiang H; Kokado Y; Takahara S
    Transpl Int; 1992; 5 Suppl 1():S290-5. PubMed ID: 14621804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte hemolytic activity as an immunologic indicator of allograft rejection in rat skin transplantation.
    Moutabarrik A; Ishibashi M; Kameoka H; Takahara S; Kokado Y; Jiang H; Takano Y; Sonoda T
    Transplant Proc; 1992 Feb; 24(1):403-7. PubMed ID: 1347184
    [No Abstract]   [Full Text] [Related]  

  • 4. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel effector monocytes against human RBC antigens invading rejected renal allografts.
    Ishibashi M; Kokado Y; Takahara S; Ichikawa Y; Sonoda T
    Transplant Proc; 1988 Apr; 20(2):285-8. PubMed ID: 3284056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of selectin-dependent adhesion in cardiac allograft rejection.
    Yamazaki S; Isobe M; Suzuki J; Tojo S; Horie S; Okubo Y; Sekiguchi M
    J Heart Lung Transplant; 1998 Oct; 17(10):1007-16. PubMed ID: 9811410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat.
    Pratt JR; Hibbs MJ; Laver AJ; Smith RA; Sacks SH
    Am J Pathol; 1996 Dec; 149(6):2055-66. PubMed ID: 8952538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy.
    Li R; Chen G; Guo H; Wang DW; Xie L; Wang SS; Wang WY; Xiong YL; Chen S
    Transplant Proc; 2006 Dec; 38(10):3263-5. PubMed ID: 17175243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Deazaadenosine prevents leukocyte invasion by suppression of adhesion molecule expression during acute cardiac allograft rejection: involvement of apoptotic cell death.
    Fingerhuth H; Hölschermann H; Grimm H; Tillmanns H; Haberbosch W; Braun-Dullaeus RC; Stadlbauer TH
    J Heart Lung Transplant; 2004 Aug; 23(8):970-8. PubMed ID: 15312827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial analysis of cytokines, adhesion molecule expression, and humoral responses during development of chronic kidney allograft rejection in a new rat model.
    Tilney NL; Whitley WD; Tullius SG; Heemann UW; Wasowska B; Baldwin WM; Hancock WW
    Transplant Proc; 1993 Feb; 25(1 Pt 2):861-2. PubMed ID: 8442249
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection.
    Zehr KJ; Herskowitz A; Lee PC; Poston RS; Gillinov AM; Baumgartner WA
    J Heart Lung Transplant; 1993; 12(5):837-44; discussion 844-5. PubMed ID: 8241225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
    Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oligosaccharides on rejection and reperfusion injury after lung transplantation.
    Brandt M; Boeke K; Phillips ML; Steinhoff G; Haverich A
    J Heart Lung Transplant; 1997 Mar; 16(3):352-9. PubMed ID: 9087879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
    Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
    [No Abstract]   [Full Text] [Related]  

  • 20. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
    Schrepfer S; Deuse T; Schäfer H; Reichenspurner H
    Transpl Int; 2005 Feb; 18(2):215-20. PubMed ID: 15691275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.